PIK3R1 and cancer: The post-treatment samples had very large numbers of unique mutations across the VAF spectrum and these included potential driver changes in PIK3R1 and KMT2D. The genomic evolution of the MSI+ cancers strongly suggested that these were polyclonal tumours.